Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Vivosim Lab Inc (VIVS)

Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer GlobeNewswire - Tue Jan 6, 7:05AM CST

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing...

VIVS : 2.0000 (+0.50%)
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer GlobeNewswire - Thu Aug 14, 2025

SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing...

VIVS : 2.0000 (+0.50%)
VivoSim: Fiscal Q1 Earnings Snapshot AP - Tue Aug 12, 2025

VivoSim: Fiscal Q1 Earnings Snapshot

VIVS : 2.0000 (+0.50%)
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference GlobeNewswire - Tue May 13, 2025

VIVS : 2.0000 (+0.50%)
VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference GlobeNewswire - Wed May 7, 2025

VIVS : 2.0000 (+0.50%)
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market GlobeNewswire - Thu Apr 24, 2025

VIVS : 2.0000 (+0.50%)
ONVO : 2.04 (+1.49%)

Barchart Exclusives

Power Up for a Larger Rally in 1 of 2026’s Winning AI Stocks with a Bull Call Spread Barchart - 34 minutes ago
The technicals in this AI infrastructure stock support more upside ahead. How to trade it now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot